Fate Therapeutics(DE:F6T)
€1.56-0.12 (-7.15%)
DE:F6T
Fate Therapeutics earnings date
€1.56
At close:-0.12 (-7.15%)
Fate Therapeutics (F6T) Q2 2022 Earnings Report
1 Followers
DE:F6T Q2 2022 EPS Results
- Actual EPS
- -EUR 0.71
- Consensus EPS
- -EUR 0.74
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- -EUR 0.52
DE:F6T Q2 2022 Revenue Results
- Actual Revenue
- EUR 16.61M
- Expected Revenue
- EUR 11.22M
- Beat/Miss
- Beat by +EUR 5.38M
- YoY Revenue Growth
- +38.30%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/03/2022
- Time
- After Close
- Conference Call
- Wednesday, August 3, 2022
DE:F6T Upcoming Earnings
Fate Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:F6T Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.23- | -0.24 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.24-0.22 | -0.24 | 7.41% (+0.02) | |
| Aug 13, 2026 | 2026 (Q2) | -0.24-0.22 | -0.26 | 13.79% (+0.04) | |
| May 13, 2026 | 2026 (Q1) | -0.25-0.23 | -0.29 | 18.75% (+0.05) | |
| Feb 26, 2026 | 2025 (Q4) | -0.24-0.24 | -0.39 | 38.64% (+0.15) | |
| Nov 13, 2025 | 2025 (Q3) | -0.26-0.24 | -0.36 | 32.50% (+0.12) | |
| Aug 12, 2025 | 2025 (Q2) | -0.31-0.26 | -0.3 | 12.12% (+0.04) | |
| May 13, 2025 | 2025 (Q1) | -0.34-0.29 | -0.42 | 31.91% (+0.13) | |
| Mar 05, 2025 | 2024 (Q4) | -0.39-0.39 | -0.4 | 2.22% (+0.01) | |
| Nov 12, 2024 | 2024 (Q3) | -0.37-0.36 | -0.41 | 13.04% (+0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
